Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-22

Clinical Trial Update: Real World CCH Study in Adult Females With Cellulite [Phase 3]

View source ↗

Summary

Phase 3 real-world trial update for adult females with cellulite related to Edematous Fibrosclerotic Panniculopathy (EFP) completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite | Phase 3 | Status: COMPLETED | Results posted: 2022-02-22